Aquatic Capital Management LLC Tyra Biosciences, Inc. Transaction History

Aquatic Capital Management LLC

  • $5.08 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$7.06 - $10.86 $13,858 - $21,318
1,963 Added 16.66%
13,744 $131,000
Q1 2025

May 15, 2025
BUY
$9.3 - $16.73 $66,913 - $120,372
7,195 Added 156.89%
11,781 $109,000
Q4 2024

Feb 14, 2025
BUY
$13.9 - $28.61 $63,745 - $131,205
4,586 New
4,586 $63,000

Others Institutions Holding TYRA

# of Institutions
114
Shares Held
58.1M
Call Options Held
23.5K
Put Options Held
0
View Full List

About Tyra Biosciences, Inc.

TYRA Quotes by TradingView
  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $652M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email